Lista de obras - David Cipolla - Dominio Público Uruguay

Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals

artículo científico publicado en 2015

Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties

artículo científico publicado en 2014

Characterization of aerosols of human recombinant deoxyribonuclease I (rhDNase) generated by jet nebulizers.

artículo científico publicado en 1994

Coarse spray delivery to a localized region of the pulmonary airways for gene therapy.

artículo científico publicado en 2000

Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.

artículo científico publicado en 2015

Correction: Formation of drug nanocrystals under nanoconfinement afforded by liposomes

scholarly article in RSC Advances, vol. 6 no. 15, 2016

Current and Emerging Inhaled Therapies of Repositioned Drugs

artículo científico publicado en 2018

Development and Characterization of an In Vitro Release Assay for Liposomal Ciprofloxacin for Inhalation

article

Development of Liposomal Ciprofloxacin to Treat Lung Infections

artículo científico publicado en 2016

Direct Comparison of Standard Transmission Electron Microscopy and Cryogenic-TEM in Imaging Nanocrystals Inside Liposomes

scientific article published on 27 February 2019

Drug nanocrystallisation within liposomes

scientific article published on 02 September 2018

Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin

scientific article published on 24 September 2018

Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report

artículo científico publicado en 2012

Formation of drug nanocrystals under nanoconfinement afforded by liposomes

scholarly article in RSC Advances, vol. 6 no. 8, 2016

In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.

artículo científico publicado en 2013

Inhalation delivery systems with compliance and disease management capabilities

artículo científico publicado en 1998

Inhaled antibiotics to treat lung infection

artículo científico publicado en 2013

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.

artículo científico publicado en 2013

Investigation of protein-surfactant interactions by analytical ultracentrifugation and electron paramagnetic resonance: the use of recombinant human tissue factor as an example

artículo científico publicado en 1999

Lipid-based carriers for pulmonary products: preclinical development and case studies in humans

artículo científico publicado en 2014

Liposomal formulations for inhalation

artículo científico

Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia

artículo científico publicado en 2012

Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection

scientific article published on 26 April 2019

Modifying the release properties of liposomes toward personalized medicine.

artículo científico publicado en 2014

Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop.

artículo científico publicado en 2016

Personalizing aerosol medicine: development of delivery systems tailored to the individual

artículo científico publicado en 2010

Pulmonary formulations: what remains to be done?

artículo científico publicado en 2010

Solid State Characterization of Ciprofloxacin Liposome Nanocrystals

scientific article published on 29 November 2018

Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.

artículo científico publicado en 2018

Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug

artículo científico publicado en 2016

Will pulmonary drug delivery for systemic application ever fulfill its rich promise?

artículo científico publicado en 2016

Lista de obras de David Cipolla

Aerosol Performance and Stability of Liposomes Containing Ciprofloxacin Nanocrystals

Aerosol performance and long-term stability of surfactant-associated liposomal ciprofloxacin formulations with modified encapsulation and release properties

Characterization of aerosols of human recombinant deoxyribonuclease I (rhDNase) generated by jet nebulizers.

Coarse spray delivery to a localized region of the pulmonary airways for gene therapy.

Comment on: inhaled antimicrobial therapy--barriers to effective treatment, by J. Weers, inhaled antimicrobial therapy - barriers to effective treatment, Adv. Drug Deliv. Rev. (2015), http://dx.doi.org/10.1016/j.addr.2014.08.013.

Correction: Formation of drug nanocrystals under nanoconfinement afforded by liposomes

Current and Emerging Inhaled Therapies of Repositioned Drugs

Development and Characterization of an In Vitro Release Assay for Liposomal Ciprofloxacin for Inhalation

Development of Liposomal Ciprofloxacin to Treat Lung Infections

Direct Comparison of Standard Transmission Electron Microscopy and Cryogenic-TEM in Imaging Nanocrystals Inside Liposomes

Drug nanocrystallisation within liposomes

Effective Treatment of Mycobacterium avium subsp. hominissuis and Mycobacterium abscessus Species Infections in Macrophages, Biofilm, and Mice by Using Liposomal Ciprofloxacin

Equivalence considerations for orally inhaled products for local action-ISAM/IPAC-RS European Workshop report

Formation of drug nanocrystals under nanoconfinement afforded by liposomes

In vitro and ex vivo methods predict the enhanced lung residence time of liposomal ciprofloxacin formulations for nebulisation.

Inhalation delivery systems with compliance and disease management capabilities

Inhaled antibiotics to treat lung infection

Inhaled, dual release liposomal ciprofloxacin in non-cystic fibrosis bronchiectasis (ORBIT-2): a randomised, double-blind, placebo-controlled trial.

Investigation of protein-surfactant interactions by analytical ultracentrifugation and electron paramagnetic resonance: the use of recombinant human tissue factor as an example

Lipid-based carriers for pulmonary products: preclinical development and case studies in humans

Liposomal formulations for inhalation

Liposomal nanoparticles control the uptake of ciprofloxacin across respiratory epithelia

Microbiological changes observed over 48 weeks of treatment with inhaled liposomal ciprofloxacin in individuals with non-cystic fibrosis bronchiectasis and chronic Pseudomonas aeruginosa lung infection

Modifying the release properties of liposomes toward personalized medicine.

Patient Focus and Regulatory Considerations for Inhalation Device Design: Report from the 2015 IPAC-RS/ISAM Workshop.

Personalizing aerosol medicine: development of delivery systems tailored to the individual

Pulmonary formulations: what remains to be done?

Solid State Characterization of Ciprofloxacin Liposome Nanocrystals

Sweetening Inhaled Antibiotic Treatment for Eradication of Chronic Respiratory Biofilm Infection.

Tuning Ciprofloxacin Release Profiles from Liposomally Encapsulated Nanocrystalline Drug

Will pulmonary drug delivery for systemic application ever fulfill its rich promise?